Earnings History Data for Genocea Biosciences, Inc. (GNCA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Genocea Biosciences, Inc.

Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections, GEN-004 and HSV-2 prophylaxis and malaria. Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-03-2022	PM	7:00 AM ET (Mar 10)	GNCA	Genocea Biosciences, Inc.	61.47	-0.19	-0.18	-0.18	Genocea Biosciences GAAP EPS of -$0.19 misses by $0.01 [3/10/2022 7:02 AM]	1.16	-0.03 (-2.62%)	1.19	0.0 (0.00%)	0.0 - 0.0	91,602	0	0
Genocea Biosciences Q4 2021 Earnings Preview [3/9/2022 11:37 AM] Genocea Biosciences GAAP EPS of -$0.19 misses by $0.01 [3/10/2022 7:02 AM] Genocea Provides Fourth Quarter 2021 Corporate Update [Mar-10-22 07:00AM]
28-10-2021	PM	7:00 AM ET (Oct 28)	GNCA	Genocea Biosciences, Inc.	100.92	-0.05	-0.20	-0.26	Genocea Biosciences EPS beats by $0.16 [10/28/2021 7:07 AM]	1.75	0.08 (4.79%)	1.70	0.03 (1.80%)	1.65 - 4.04	593,851	100,000	6,422
Genocea Biosciences Q3 2021 Earnings Preview [10/27/2021 1:53 PM] Genocea Biosciences EPS beats by $0.16 [10/28/2021 7:07 AM] Genocea Provides Third Quarter 2021 Corporate Update [Oct-28-21 07:00AM]
29-07-2021	PM	7:00 AM ET (Jul 29)	GNCA	Genocea Biosciences, Inc.	110.50	-0.20	-0.18	-0.39	Genocea Biosciences EPS misses by $0.02 [7/29/2021 7:21 AM]	2.02	-0.01 (-0.49%)	0.0	0.0 (0.00%)	1.80 - 5.59	49,411	110,000	0
Genocea Biosciences EPS misses by $0.02 [7/29/2021 7:21 AM] Genocea Provides Second Quarter 2021 Corporate Update [Jul-29-21 07:00AM]
29-04-2021	PM	7:30 AM ET (Apr 29)	GNCA	Genocea Biosciences, Inc.	146.11	-0.17	-0.20	-0.46	Genocea Biosciences EPS beats by $0.03 [4/29/2021 7:18 AM]	2.66	0.06 (2.31%)	2.60	0.0 (0.00%)	1.74 - 5.75	201,719	340,000	1,772
Genocea Biosciences EPS beats by $0.03 [4/29/2021 7:18 AM] Genocea Biosciences, Inc. to Host Earnings Call [Apr-29-21 06:30AM] Genocea Provides First Quarter 2021 Corporate Update [Apr-29-21 07:00AM] Genocea Biosciences (GNCA) Reports Q1 Loss, Misses Revenue Estimates [Apr-29-21 08:55AM]
11-02-2021	PM	7:00 AM ET (Feb 11)	GNCA	Genocea Biosciences, Inc.	184.85	-0.18	-0.21	-0.34	Genocea Biosciences EPS beats by $0.03 [2/11/2021 7:32 AM]	3.28	-0.10 (-2.96%)	3.61	0.23 (6.80%)	1.10 - 5.75	746,909	835,047	39,259
Genocea Biosciences EPS beats by $0.03 [2/11/2021 7:32 AM] Genocea Provides Fourth Quarter 2020 Corporate Update [Feb-11-21 07:30AM] Genocea Biosciences, Inc. to Host Earnings Call [Feb-11-21 06:30AM]
29-10-2020	PM	7:00 AM ET (Oct 29)	GNCA	Genocea Biosciences, Inc.	116.06	-0.26	-0.24	-0.28	Genocea Biosciences EPS misses by $0.02 [10/29/2020 7:08 AM]	2.12	-0.15 (-6.61%)	2.22	-0.05 (-2.20%)	1.10 - 5.75	504,676	224,989	5,754